Efficacy of a multidisciplinary treatment program in patients with severe fibromyalgia
Rheumatology International,

Casanueva–Fernandez B et al. – Patients with severe manifestations of fibromyalgia can obtain improvement with a short–term, low–cost and simple–delivery multidisciplinary program. However, additional studies including higher numbers of patients are needed to confirm the beneficial effect of this treatment program.

Methods
  • Thirty–four fibromyalgia patients were randomly divided into two groups.
  • The control group: 17 women who continued their medical treatment and participated in four educational sessions and the experimental group that included 17 patients who besides the former medical treatment also underwent a weekly 1–h session program for 8 weeks including massage therapy, ischemic pressure on the 18 tender points, aerobic exercise and thermal therapy.

Results
  • At the beginning of the program, there were no significant differences between the two groups in any of the parameters.
  • At the end of treatment, there was a significant improvement in the experimental group in the following items: vitality, social functioning, grip strength and the 6–min walk test.
  • At 1 month after the end of treatment, the experimental group showed significant differences in overall health perception, social functioning, grip strength and the 6–min walk test.
  • At that time, considering the threshold for clinical efficacy set at an improvement of 30% or above for the analyzed variables, 25% of the patients met the requirement for improvement of the following: number of symptoms: Visual Analogic Scale for fatigue, Fibromyalgia Impact Questionnaire and Beck Anxiety Inventory.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

<

Most Popular Rheumatology Articles

1 Immune fault linked to disease University of Edinburgh College of Medicine News, December 1, 2014

2 A combination of celecoxib and famciclovir is efficacious in the treatment of fibromyalgia: Results of a phase IIa randomized, double-blind, placebo-controlled study American College of Rheumatology News, December 2, 2014    Clinical Article

3 The association of serum anti-ribosomal P antibody with clinical and serological disorders in systemic lupus erythematosus: A systematic review and meta-analysis Lupus, November 26, 2014    Evidence Based Medicine    Review Article

4 Coffee or tea consumption and the risk of rheumatoid arthritis: A meta-analysis Clinical Rheumatology, October 15, 2014    Clinical Article

5 Blood test could prevent medication trial and error for rheumatoid arthritis patients Mayo Clinic, November 18, 2014

6 The comparative safety of TNF inhibitors in rheumatoid arthritis - a meta-analysis update of 44 randomized controlled trials American Journal of Medicine, October 6, 2014    Clinical Article

7 Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis Rheumatology, December 8, 2014    Clinical Article

8 Yearly treatment could slow osteoarthritis Monash University News, September 23, 2014

9 Ten common mistakes in the management of lupus nephritis American Journal of Kidney Diseases, January 3, 2014    Clinical Article

10 Tramadol and risk of hospitalization for hypoglycemia McGill University News, December 10, 2014

11 Methotrexate and lung disease in rheumatoid arthritis – A meta-analysis of randomized controlled trials Arthritis & Rheumatism, December 27, 2013    Evidence Based Medicine    Review Article    Clinical Article

12 Mayo Clinic researchers: TNF inhibitors may increase cancer risk in the eye Mayo Clinic, November 19, 2014

13 Lupus enteritis: Clinical characteristics and predictive factors for recurrence Lupus, December 4, 2014    Clinical Article

14 Safety and efficacy of ifalimumab, an anti IFN-alpha monoclonal antibody, in a phase 2b study of moderate to severe systemic lupus erythematosus American College of Rheumatology News, November 25, 2014

15 Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis International Journal of Rheumatic Diseases, December 11, 2014    Clinical Article

16 Fish consumption and risk of rheumatoid arthritis: A dose-response meta-analysis Arthritis Research & Therapy, October 8, 2014    Evidence Based Medicine    Review Article

17 Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids Rheumatology, December 10, 2014    Clinical Article

18 Adalimumab for steroid sparing in patients with giant-cell arteritis: Results of a multicentre randomised controlled trial Annals of Rheumatic Diseases, November 10, 2014    Clinical Article

19 Electrical stimulation for pain relief in knee osteoarthritis: Systematic review and network meta-analysis Osteoarthritis and Cartilage , December 4, 2014    Evidence Based Medicine    Review Article

20 Current evidence on risk factors for knee osteoarthritis in older adults: A systematic review and meta-analysis Osteoarthritis and Cartilage , December 2, 2014    Evidence Based Medicine    Review Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List